These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1715489)

  • 21. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Load responsiveness of protein synthesis in adult mammalian myocardium: role of cardiac deformation linked to sodium influx.
    Kent RL; Hoober JK; Cooper G
    Circ Res; 1989 Jan; 64(1):74-85. PubMed ID: 2909303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension.
    Jadhav A; Ndisang JF
    Exp Biol Med (Maywood); 2009 Jul; 234(7):764-78. PubMed ID: 19429856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways.
    Ruwhof C; van der Laarse A
    Cardiovasc Res; 2000 Jul; 47(1):23-37. PubMed ID: 10869527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.
    Izumiya Y; Shiojima I; Sato K; Sawyer DB; Colucci WS; Walsh K
    Hypertension; 2006 May; 47(5):887-93. PubMed ID: 16567591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
    Yang XP; Samaja M; English E; Benatti P; Tarantola M; Cardace G; Motterlini R; Micheletti R; Bianchi G
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
    Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanism of cardiac cellular hypertrophy by mechanical stress.
    Yamazaki T; Komuro I; Yazaki Y
    J Mol Cell Cardiol; 1995 Jan; 27(1):133-40. PubMed ID: 7760338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic aspects of the development of experimental cardiac hypertrophy.
    Zimmer HG; Peffer H
    Basic Res Cardiol; 1986; 81 Suppl 1():127-37. PubMed ID: 3024615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.
    Weber KT; Clark WA; Janicki JS; Shroff SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S37-50. PubMed ID: 2485029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transfer in cardiac muscle. Alteration of the beta-adrenoceptor adenylate cyclase system in the hypertrophied myocardium.
    Will-Shahab L; Küttner I; Warbanow W
    Biomed Biochim Acta; 1986; 45(1-2):S199-204. PubMed ID: 3008709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between haemodynamic and metabolic changes in three models of experimental cardiac hypertrophy.
    Zimmer HG
    Eur Heart J; 1984 Dec; 5 Suppl F():171-9. PubMed ID: 6099802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphofunctional basis of development of the "hypertonic heart"].
    Frolov VA; Drozdova GA
    Arkh Patol; 1982; 44(5):35-41. PubMed ID: 6214242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Load induction of cardiac hypertrophy.
    Cooper G; Kent RL; Mann DL
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():11-30. PubMed ID: 2483414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
    Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L
    Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease.
    Weber KT; Jalil JE; Janicki JS; Pick R
    Am J Hypertens; 1989 Dec; 2(12 Pt 1):931-40. PubMed ID: 2532916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and pathological cardiac hypertrophy.
    Shimizu I; Minamino T
    J Mol Cell Cardiol; 2016 Aug; 97():245-62. PubMed ID: 27262674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation.
    Mann DL; Kent RL; Cooper G
    Circ Res; 1989 Jun; 64(6):1079-90. PubMed ID: 2470528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.